| Year |
Citation |
Score |
| 2019 |
Perreault S, de Denus S, White-Guay B, Côté R, Schnitzer ME, Dubé MP, Dorais M, Tardif JC. Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation. Pharmacotherapy. PMID 31758592 DOI: 10.1016/J.Jval.2019.09.039 |
0.302 |
|
| 2019 |
Khanji C, Schnitzer ME, Bareil C, Perreault S, Lalonde L. Concordance of care processes between medical records and patient self-administered questionnaires. Bmc Family Practice. 20: 92. PMID 31269902 DOI: 10.1186/S12875-019-0979-7 |
0.305 |
|
| 2017 |
Kuate Defo B, Mbanya JC, Tardif JC, Ekundayo O, Perreault S, Potvin L, Cote R, Kengne AP, Choukem SP, Assah F, Kingue S, Richard L, Pongou R, Frohlich K, Saji J, et al. Diagnosis, Prevalence, Awareness, Treatment, Prevention, and Control of Hypertension in Cameroon: Protocol for a Systematic Review and Meta-Analysis of Clinic-Based and Community-Based Studies. Jmir Research Protocols. 6: e102. PMID 28554882 DOI: 10.2196/Resprot.7807 |
0.334 |
|
| 2016 |
Perreault S, Klein AB, Morlock R. FRI0594 Association of Gout Diagnosis with Increased Risk of Joint Replacement: A Population-Based Cohort Study of over 250,000 Patients Annals of the Rheumatic Diseases. 75: 657-657. DOI: 10.1136/Annrheumdis-2016-Eular.4463 |
0.323 |
|
| 2015 |
Lalonde L, Choinière M, Martin E, Lévesque L, Hudon E, Bélanger D, Perreault S, Lacasse A, Laliberté MC. Priority interventions to improve the management of chronic non-cancer pain in primary care: a participatory research of the ACCORD program. Journal of Pain Research. 8: 203-15. PMID 25995648 DOI: 10.2147/Jpr.S78177 |
0.624 |
|
| 2015 |
Perreault S, Nuevo J, Baumgartner S, Morlock R. AB1180 Persistence Rate and Adherence Level to Allopurinol Among Patients with Gout Diagnosis and their Associated Determinants with Hypertensive Patients Annals of the Rheumatic Diseases. 74: 1297-1297. DOI: 10.1136/Annrheumdis-2015-Eular.5003 |
0.335 |
|
| 2015 |
Perreault S, Nuevo J, Baumgartner S, Morlock R. THU0371 Compliance with Allopurinol Among Hypertensive Patients with Gout Diagnosis and the Relationship to Onset of End-Stage Renal Disease Annals of the Rheumatic Diseases. 74: 330-330. DOI: 10.1136/Annrheumdis-2015-Eular.4962 |
0.321 |
|
| 2013 |
Roy L, White-Guay B, Dorais M, Dragomir A, Lessard M, Perreault S. Adherence to antihypertensive agents improves risk reduction of end-stage renal disease. Kidney International. 84: 570-7. PMID 23698228 DOI: 10.1038/Ki.2013.103 |
0.314 |
|
| 2012 |
Pariente A, Fourrier-Réglat A, Bazin F, Ducruet T, Dartigues JF, Dragomir A, Perreault S, Moore N, Moride Y. Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitors Neurology. 78: 957-963. PMID 22422894 DOI: 10.1212/Wnl.0B013E31824D5773 |
0.304 |
|
| 2012 |
Laliberté MC, Perreault S, Damestoy N, Lalonde L. Ideal and actual involvement of community pharmacists in health promotion and prevention: a cross-sectional study in Quebec, Canada. Bmc Public Health. 12: 192. PMID 22420693 DOI: 10.1186/1471-2458-12-192 |
0.611 |
|
| 2012 |
Perreault S, Yu AYX, Côté R, Dragomir A, White-guay B, Dumas S. PCV83 Adherence to Antihypertensive Agents After a Recent Ischemic Stroke and Risk of Cardiovascular Outcomes : A Population Based Study Value in Health. 15. DOI: 10.1016/J.Jval.2012.08.1026 |
0.346 |
|
| 2011 |
Laliberté MC, Perreault S, Jouini G, Shea BJ, Lalonde L. Effectiveness of interventions to improve the detection and treatment of osteoporosis in primary care settings: a systematic review and meta-analysis. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 22: 2743-68. PMID 21336493 DOI: 10.1007/S00198-011-1557-6 |
0.333 |
|
| 2011 |
Lalonde L, Hudon E, Goudreau J, Bélanger D, Villeneuve J, Perreault S, Blais L, Lamarre D. Physician-pharmacist collaborative care in dyslipidemia management: the perception of clinicians and patients. Research in Social & Administrative Pharmacy : Rsap. 7: 233-45. PMID 21272548 DOI: 10.1016/J.Sapharm.2010.05.003 |
0.319 |
|
| 2010 |
Louis KM, Martineau J, Rodrigues I, Fournier M, Berbiche D, Blais N, Ginsberg J, Blais L, Montigny M, Perreault S, Vanier MC, Lalonde L. Primary care practices and determinants of optimal anticoagulation management in a collaborative care model. American Heart Journal. 159: 183-9. PMID 20152215 DOI: 10.1016/J.Ahj.2009.11.015 |
0.32 |
|
| 2010 |
Laliberté MC, Perreault S, Dragomir A, Goudreau J, Rodrigues I, Blais L, Damestoy N, Corbeil D, Lalonde L. Impact of a primary care physician workshop on osteoporosis medical practices. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 21: 1471-85. PMID 19937428 DOI: 10.1007/S00198-009-1116-6 |
0.316 |
|
| 2010 |
Dragomir A, Côté R, White M, Lalonde L, Blais L, Bérard A, Perreault S. Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 13: 87-94. PMID 19695008 DOI: 10.1111/J.1524-4733.2009.00583.X |
0.301 |
|
| 2009 |
Villeneuve J, Lamarre D, Lussier MT, Vanier MC, Genest J, Blais L, Hudon E, Perreault S, Berbiche D, Lalonde L. Physician-pharmacist collaborative care for dyslipidemia patients: knowledge and skills of community pharmacists. The Journal of Continuing Education in the Health Professions. 29: 201-8. PMID 19998453 DOI: 10.1002/Chp.20038 |
0.301 |
|
| 2009 |
Perreault S, Dragomir A, White M, Lalonde L, Blais L, Bérard A. Better adherence to antihypertensive agents and risk reduction of chronic heart failure Journal of Internal Medicine. 266. PMID 19623691 DOI: 10.1111/J.1365-2796.2009.02084.X |
0.333 |
|
| 2009 |
Blouin J, Dragomir A, Fredette M, Ste-Marie LG, Fernandes JC, Perreault S. Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: a population-based study. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 20: 1571-81. PMID 19107385 DOI: 10.1007/S00198-008-0818-5 |
0.311 |
|
| 2009 |
Kettani FZ, Dragomir A, Côté R, Roy L, Bérard A, Blais L, Lalonde L, Moreau P, Perreault S. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke; a Journal of Cerebral Circulation. 40: 213-20. PMID 19038916 DOI: 10.1161/Strokeaha.108.522193 |
0.314 |
|
| 2008 |
Perreault S, Dragomir A, Blais L, Bérard A, Lalonde L, White M. Impact of adherence to statins on chronic heart failure in primary prevention. British Journal of Clinical Pharmacology. 66: 706-16. PMID 18754842 DOI: 10.1111/J.1365-2125.2008.03269.X |
0.303 |
|
| 2008 |
Lalonde L, Martineau J, Blais N, Montigny M, Ginsberg J, Fournier M, Berbiche D, Vanier MC, Blais L, Perreault S, Rodrigues I. Is long-term pharmacist-managed anticoagulation service efficient? A pragmatic randomized controlled trial. American Heart Journal. 156: 148-54. PMID 18585510 DOI: 10.1016/J.Ahj.2008.02.009 |
0.315 |
|
| 2007 |
Gogovor A, Dragomir A, Savoie M, Perreault S. Comparison of persistence rates with angiotensin-converting enzyme inhibitors used in secondary and primary prevention of cardiovascular disease. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 10: 431-41. PMID 17888108 DOI: 10.1111/J.1524-4733.2007.00247.X |
0.338 |
|
| 2007 |
Villeneuve J, Lamarre D, Vanier MC, Lussier MT, Genest J, Hudon E, Blais L, Perreault S, Lalonde L. How to help patients manage their dyslipidemia: A primary care physician-pharmacist team intervention Canadian Pharmacists Journal. 140: 300-305. DOI: 10.3821/1913-701X(2007)140[300:Hthpmt]2.0.Co;2 |
0.318 |
|
| 2006 |
Makhzoum J, Jobin G, Dagenais P, Makhzoum S, Perreault S. Risk for osteoporosis and antiresorptive therapies in patients with Crohn's disease Journal of Pharmacy Technology. 22: 9-14. DOI: 10.1177/875512250602200103 |
0.324 |
|
| 2005 |
Perreault S, Lamarre D, Blais L, Dragomir A, Berbiche D, Lalonde L, Laurier C, St-Maurice F, Collin J. Persistence with treatment in newly treated middle-aged patients with essential hypertension. The Annals of Pharmacotherapy. 39: 1401-8. PMID 16076920 DOI: 10.1345/Aph.1E548 |
0.3 |
|
| 2005 |
Perreault S, Blais L, Lamarre D, Dragomir A, Berbiche D, Lalonde L, Laurier C, St-Maurice F, Collin J. Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention British Journal of Clinical Pharmacology. 59: 564-573. PMID 15842555 DOI: 10.1111/J.1365-2125.2005.02355.X |
0.343 |
|
| 2005 |
Perreault S, Levinton C, Laurier C, Moride Y, Ste-Marie LG, Crott R. Validation of a decision model for preventive pharmacological strategies in postmenopausal women. European Journal of Epidemiology. 20: 89-101. PMID 15756909 DOI: 10.1007/S10654-004-9478-8 |
0.306 |
|
| 2005 |
Moride Y, Ducruet T, Boivin JF, Moore N, Perreault S, Zhao S. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study. Arthritis Research & Therapy. 7: R333-42. PMID 15743481 DOI: 10.1186/Ar1488 |
0.308 |
|
| 2000 |
LeLorier J, Perreault S, Birnbaum H, Greenberg P, Sheehy O. Savings in direct medical costs from the use of tobramycin solution for inhalation in patients with cystic fibrosis Clinical Therapeutics. 22: 140-151. PMID 10688397 DOI: 10.1016/S0149-2918(00)87985-0 |
0.314 |
|
| 1998 |
Choinière M, Rittenhouse BE, Perreault S, Chartrand D, Rousseau P, Smith B, Pepler C. Efficacy and costs of patient-controlled analgesia versus regularly administered intramuscular opioid therapy Anesthesiology. 89: 1377-1388. PMID 9856712 DOI: 10.1097/00000542-199812000-00015 |
0.307 |
|
| Show low-probability matches. |